Solutions for severe headache and migraine provided by Specialist Neurologists
Headache and migraine are a major cause of disability in the community.
Episodic Migraine are headaches that develop up to 7 times per month and settle with or without treatment. You need an emergency management plan ready to treat these painful and severe headaches. Lifestyle changes, avoidance of triggers, physical therapies and sometimes regular medications (preventers) are helpful.
Chronic Migraine are headaches, head pain and migrainous ‘flares’ that occur more than 14 days per month. Chronic pain and impairment may have been present for many years. It is most important to carefully consider medication use with an expert, avoid triggers and look at physical therapies.
At our state-wide group of consulting locations, specialist doctors use injectable therapies (CGRP inhibitors, anti-wrinkle muscle relaxant) and infusion therapies to treat chronic migraine.
Expert Neurologists who practice at NNM will put together a carefully considered, evidence-based management plan to improve migraine.
Do you have Chronic Migraine? Are your headaches:
- Occurring more than 14 days per month?
- Requiring frequent pain relief?
- Have you used migraine preventers?
Then you may have chronic migraine which is the most severe form because of the persistence and long-term pain. Treatment can be difficult but injectable treatments have been shown to help many patients, even when other therapies have failed. You may qualify for the injectable medication subsidised by the PBS if you have tried several headache preventers.
At Neurology Network Melbourne we have over 40 doctors’ practices, including practices that specialize primarily in the treatment of these severe headaches and provide injectable treatments.
What are CGRP inhibitors?
Today most experts believe that migraine is a neurological disorder that begins inside the brain, occurring primarily in the brainstem with the activation of certain brain structures.
These same brain structures cause peptides including CGRP, to be released.
CGRP then binds to receptors which leads to vasodilation and muscle relaxation which leads to inflammation and pain.
The released peptides bind to specific receptors which cause sensitisation. (2) Ordinary stimuli such as light, sound and smell can then cause pain.
The secret of this latest generation of CGRP treatment is inhibiting CGRP through use of monoclonal antibodies.
Calcitonin Gene-Related Peptide Antibodies (CGRP) for Migraine
Infusion therapies for Migraine. Do you qualify for Vyepti?
Vyepti is a new preventive treatment for migraine. It is part of a class of medications called calcitonin gene-related peptide (CGRP) monoclonal antibodies.
Preventive treatments like Vyepti are generally recommended for anyone living with chronic or debilitating migraine attacks. However, there are many different medications available, and it can be hard to decide which one might be best for you.
Vyepti is part of a group of drugs called calcitonin gene-related peptide (CGRP) monoclonal antibodies. These are the newest type of preventive migraine medication, and the first preventive treatment to be designed specifically for migraine.
Vyepti is delivered via an intravenous infusion, that requires nursing oversight and a small needed. (From 2026) these infusions can be performed at the Neurology Network rooms in St Kilda Rd, Fitzroy and Box Hill. While for patients who qualify, the drug is subsidised by PBS, there are additional costs for the infusion attendance.